LEVIN JEREMY M 4
4 · Ovid Therapeutics Inc. · Filed Feb 24, 2025
Insider Transaction Report
Form 4
LEVIN JEREMY M
DirectorCEO
Transactions
- Award
Employee Stock Option (Right to Buy)
2025-02-20+1,650,000→ 1,650,000 totalExercise: $0.57Exp: 2035-02-19→ Common Stock (1,650,000 underlying)
Footnotes (1)
- [F1]The shares subject to the stock option will vest in 48 equal monthly installments commencing on March 20, 2025, subject to the Reporting Person's continued services through each such date.